January 3, 2018 / 8:35 AM / in 6 months

BRIEF-Pharma Mar Requests Re-Examination Process For Aplidin From EMA

Jan 3 (Reuters) - PHARMA MAR SA:

* REQUESTS PROCESS OF RE-EXAMINATION FOR APLIDIN FROM THE EUROPEAN MEDICINES AGENCY (EMA)

* AFTER FINALIZING RE-EXAMINATION PROCESS, EUROPEAN COMMISSION TO ISSUE FINAL VERDICT ON THE MARKETING AUTHORIZATION APPLICATION (MAA) FOR APLIDIN AROUND JUNE OR JULY Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below